chr6-16254730-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006877.4(GMPR):āc.460A>Gā(p.Ile154Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000435 in 1,610,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006877.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GMPR | NM_006877.4 | c.460A>G | p.Ile154Val | missense_variant | 4/9 | ENST00000259727.5 | |
GMPR | XM_047418656.1 | c.460A>G | p.Ile154Val | missense_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GMPR | ENST00000259727.5 | c.460A>G | p.Ile154Val | missense_variant | 4/9 | 1 | NM_006877.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251354Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135846
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1458448Hom.: 0 Cov.: 29 AF XY: 0.0000179 AC XY: 13AN XY: 725812
GnomAD4 genome AF: 0.000269 AC: 41AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.460A>G (p.I154V) alteration is located in exon 4 (coding exon 4) of the GMPR gene. This alteration results from a A to G substitution at nucleotide position 460, causing the isoleucine (I) at amino acid position 154 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at